Can copeptin predict the severity of coronavirus disease 2019 infection?
dc.authorid | 0000-0002-8807-5853 | en_US |
dc.contributor.author | İn, Erdal | |
dc.contributor.author | Kuluöztürk, Mutlu | |
dc.contributor.author | Telo, Selda | |
dc.contributor.author | Toraman, Zülal Aşçı | |
dc.contributor.author | Karabulut, Ercan | |
dc.date.accessioned | 2021-12-04T19:00:30Z | |
dc.date.available | 2021-12-04T19:00:30Z | |
dc.date.issued | 2021 | en_US |
dc.department | MTÖ Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | en_US |
dc.description | Original Article | en_US |
dc.description.abstract | Objetive: Coronavirus disease 2019 (COVID-19) has quickly turned into a health problem globally. Early and effective predictors of disease severity are needed to improve the management of the patients affected with COVID-19. Copeptin, a 39-amino acid glycopeptide, is known as a C-terminal unit of the precursor pre-provasopressin (pre-proAVP). Activation of AVP system stimulates copeptin secretion in equimolar amounts with AVP. This study aimed to determine serum copeptin levels in the patients with COVID-19 and to examine the relationship between serum copeptin levels and the severity of the disease. Methods: The study included 90 patients with COVID-19. The patients with COVID-19 were divided into two groups according to disease severity as mild/moderate disease (n=35) and severe disease (n=55). All basic demographic and clinical data of the patients were recorded and blood samples were collected. Results: Copeptin levels were significantly higher in the patients with severe COVID-19 compared with the patients with mild/moderate COVID-19 (p<0.001). Copeptin levels were correlated with ferritin and fibrinogen levels positively (r=0.32, p=0.002 and r=0.25, p=0.019, respectively), and correlated with oxygen saturation negatively (r=-0.37, p<0.001). In the multivariate logistic regression analysis, it was revealed that copeptin (OR: 2.647, 95%CI 1.272-5.510; p=0.009) was an independent predictor of severe COVID-19 disease. A cutoff value of 7.84 ng/mL for copeptin predicted severe COVID-19 with a sensitivity of 78% and a specificity of 80% (AUC: 0.869, 95%CI 0.797-0.940; p<0.001). Conclusion: Copeptin could be used as a favorable prognostic biomarker while determining the disease severity in COVID-19. | en_US |
dc.identifier.citation | İn, E., Kuluöztürk, M., Telo, S., Toraman, Z. A., & Karabulut, E. (2021). Can copeptin predict the severity of coronavirus disease 2019 infection?. Revista da Associação Médica Brasileira, 67(8), 1137-1142. | en_US |
dc.identifier.doi | 10.1590/1806-9282.20210525 | |
dc.identifier.endpage | 1142 | en_US |
dc.identifier.issn | 0104-4230 | en_US |
dc.identifier.issn | 1806-9282 | en_US |
dc.identifier.issue | 8 | en_US |
dc.identifier.pmid | 34669859 | |
dc.identifier.scopus | 2-s2.0-85118249097 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 1137 | en_US |
dc.identifier.uri | https://doi.org/10.1590/1806-9282.20210525 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12899/512 | |
dc.identifier.volume | 67 | en_US |
dc.identifier.wos | WOS:000708990100014 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.institutionauthor | İn, Erdal | |
dc.language.iso | en | en_US |
dc.publisher | Associação Médica Brasileira | en_US |
dc.relation.ispartof | Revista da Associação Médica Brasileira | en_US |
dc.relation.publicationcategory | Makale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | Mild/Moderate COVID-19 | en_US |
dc.subject | Severe COVID-19 | en_US |
dc.subject | Copeptin | en_US |
dc.subject | Biomarkers | en_US |
dc.title | Can copeptin predict the severity of coronavirus disease 2019 infection? | en_US |
dc.type | Article | en_US |